Theravance Biopharma (TBPH) EBITDA Margin (QoQ) (2013 - 2026)
Theravance Biopharma (TBPH) EBITDA Margin (QoQ) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-13,363.00 |
| Dec 31, 2025 |
6,175.00 |
| Sep 30, 2025 |
-19,100.00 |
| Jun 30, 2025 |
29,759.00 |
| Mar 31, 2025 |
-3,923.00 |
| Dec 31, 2024 |
2,580.00 |
| Sep 30, 2024 |
4,096.00 |
| Jun 30, 2024 |
-3,555.00 |
| Mar 31, 2024 |
-4,473.00 |
| Dec 31, 2023 |
2,112.00 |
| Sep 30, 2023 |
5,960.00 |
| Jun 30, 2023 |
9,516.00 |
| Mar 31, 2023 |
-9,241.00 |
| Dec 31, 2022 |
-748,029.00 |
| Sep 30, 2022 |
743,558.00 |
| Jun 30, 2022 |
96,468.00 |
| Mar 31, 2022 |
-66,316.00 |
| Dec 31, 2021 |
-10,824.00 |
| Sep 30, 2021 |
13,831.00 |
| Jun 30, 2021 |
15,322.00 |
